- Investor's Business Daily•54 minutes ago
Sanofi and Novo Nordisk diverged Friday on differing outlooks for the U.S. insulin market as AbbVie toppled on its Q3 sales miss.
- Financial Times•2 hours ago
One industry that could use some strong medicine is European pharmaceuticals. MSCI's European pharma index has fallen this year, trailing the regional benchmark by more than 6 percentage points. Paris-based ...
- Bloomberg•2 hours ago
Diabetes drug pricing pressure in the U.S. lead Novo Nordisk to slash its long-term profit growth target while Sanofi raised its earnings forecast. Bloomberg's Kristen Hallam examines the strategies of ...
NYSE - NYSE Real Time Price. Currency in USD
|Bid||39.04 x 200|
|Ask||39.05 x 400|
|Day's Range||38.65 - 39.37|
|52wk Range||36.81 - 50.95|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||22.31|
|Avg Vol (3m)||2,339,132|
|Dividend & Yield||1.66 (4.49%)|